v1
Histamine dihydrochloride (Maxamine®) and interferon-a-2b (IFN-a-2b) as a potential new combination therapy for chronic hepatitis C (HCV): 12- week results of a phase II trial
NobleIDNI2P82W29R58S06
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260521/08EB4B46)
ARK Inflections
Metadata Formats
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims